BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37953219)

  • 1. Latest clinical research in leptomeningeal disease (LMD)-a narrative review.
    Chan AW; Wong HCY; Taphoorn M; Dirven L; Le Rhun E; Soliman H; Oldenburger E; Raman S; Vassiliou V; Bonomo P; Koller M; Marta GN; Rembielak A; Lee SF; Chow E; Simone CB
    Ann Palliat Med; 2023 Nov; 12(6):1215-1231. PubMed ID: 37953219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for leptomeningeal disease in breast cancer.
    Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
    Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
    Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
    Piña Y; Yadugiri S; Yeboa DN; Ferguson SD; Forsyth PA; Oliva ICG
    Curr Oncol Rep; 2022 Jan; 24(1):43-54. PubMed ID: 35059999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials.
    Buszek SM; Chung C
    Front Oncol; 2019; 9():1224. PubMed ID: 31803614
    [No Abstract]   [Full Text] [Related]  

  • 7. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
    Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
    Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the Diagnosis and Treatment of Leptomeningeal Disease.
    Sharma A; Low JT; Kumthekar P
    Curr Neurol Neurosci Rep; 2022 Jul; 22(7):413-425. PubMed ID: 35588045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
    Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
    Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers.
    Jafari F; Nodeh MM; Hosseinjani H; Baharara H; Azad S; Arasteh O; Johnston TP; Sahebkar A
    Curr Med Chem; 2023 May; ():. PubMed ID: 37157199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and Therapeutic Updates in Leptomeningeal Disease.
    Roy-O'Reilly MA; Lanman T; Ruiz A; Rogawski D; Stocksdale B; Nagpal S
    Curr Oncol Rep; 2023 Aug; 25(8):937-950. PubMed ID: 37256537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy.
    Thomas KH; Ramirez RA
    Ochsner J; 2017; 17(4):362-378. PubMed ID: 29230121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
    Palmisciano P; Watanabe G; Conching A; Ogasawara C; Vojnic M; D'Amico RS
    J Neurooncol; 2022 Oct; 160(1):79-100. PubMed ID: 35999434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
    Ferguson SD; Bindal S; Bassett RL; Haydu LE; McCutcheon IE; Heimberger AB; Li J; O'Brien BJ; Guha-Thakurta N; Tetzlaff MT; Tawbi H; Davies MA; Glitza IC
    J Neurooncol; 2019 May; 142(3):499-509. PubMed ID: 30847840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation Therapy in the Management of Leptomeningeal Disease From Solid Tumors.
    Barbour AB; Kotecha R; Lazarev S; Palmer JD; Robinson T; Yerramilli D; Yang JT
    Adv Radiat Oncol; 2024 Feb; 9(2):101377. PubMed ID: 38405313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
    Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
    Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases.
    Prakadan SM; Alvarez-Breckenridge CA; Markson SC; Kim AE; Klein RH; Nayyar N; Navia AW; Kuter BM; Kolb KE; Bihun I; Mora JL; Bertalan MS; Shaw B; White M; Kaplan A; Stocking JH; Wadsworth MH; Lee EQ; Chukwueke U; Wang N; Subramanian M; Rotem D; Cahill DP; Adalsteinsson VA; Miller JW; Sullivan RJ; Carter SL; Brastianos PK; Shalek AK
    Nat Commun; 2021 Oct; 12(1):5955. PubMed ID: 34642316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries.
    Lamba N; Cagney DN; Catalano PJ; Elhalawani H; Haas-Kogan DA; Wen PY; Wagle N; Lin NU; Aizer AA; Tanguturi S
    Neuro Oncol; 2023 May; 25(5):973-983. PubMed ID: 36367837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.